TGA alert: Check Fluarix vials

In association with GSK, the TGA issued a precautionary product notification to healthcare professionals, urging them to visually inspect the vaccine prior to administration.

“The TGA has received a report that one dose of Fluarix vaccine failed to be completely administered because of a manufacturing defect, in which what appeared to be a piece of glass-like material blocked the action of the syringe,” the TGA posted on its website.

The patient was not harmed and GSK advised this type of event is rare and has occurred at a rate of one in 10 million vaccines over three years.